Multiple-testing strategy for analyzing cDNA array data on gene expression

Robert R Delongchamp1, John F Bowyer, James J Chen

  • 1Division of Biometry and Risk Assessment, National Center for Toxicological Research, Jefferson, Arkansas 72079, USA. rdelongchamp@nctr.fda.gov

Biometrics
|September 2, 2004
PubMed

Insights

This study introduces a method to optimize gene expression analysis in functional genomics. It helps researchers select the best cutoff for identifying treatment-induced gene changes while estimating false positive and negative rates.

Area of Science:

  • Genomics
  • Bioinformatics
  • Statistical Genetics

Background:

  • Functional genomics studies aim to detect treatment-induced gene expression changes using technologies like cDNA arrays.
  • Analyzing numerous gene expression comparisons presents challenges in selecting appropriate significance levels and managing multiple testing.
  • Existing methods struggle to balance false positives and false negatives, especially when prioritizing the identification of affected genes.

Purpose of the Study:

  • To develop a statistical framework for optimizing the selection of significant genes in functional genomics studies.
  • To provide methods for estimating false positive and false negative rates across various significance cutoffs.
  • To enable researchers to determine an optimal cutoff based on the relative costs of misclassification.

Main Methods:

  • Utilized p-value distribution plots to estimate the number of true null hypotheses.
  • Applied a decision-theoretic approach, analogous to receiver operating characteristic (ROC) curves, to select an optimal p-value cutoff.
  • Estimated false discovery rate (FDR) and false nondiscovery rate (FNR) for different cutoff values.

Main Results:

  • The proposed method allows for the estimation of true null hypotheses, aiding in the interpretation of p-values.
  • The decision-theoretic approach provides a data-driven way to select a cutoff that balances the trade-off between identifying true positives and minimizing false positives/negatives.
  • Demonstrated the application of these methods in two functional genomics studies to determine research-goal-specific cutoffs.

Conclusions:

  • The developed statistical methods enhance the analysis of gene expression data from functional genomics studies.
  • Researchers can effectively determine optimal significance cutoffs to maximize the discovery of treatment-affected genes while controlling error rates.
  • These techniques improve the resolution and reliability of findings in gene expression analysis.